Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-02-25 @ 3:00 AM
Study NCT ID:
NCT04605159
Status:
TERMINATED
Last Update Posted:
2025-02-20
First Post:
2020-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-14
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-22
First Submit QC Date:
None
Study First Post Date:
2020-10-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-13
Results First Submit QC Date:
None
Results First Post Date:
2024-09-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-04
Last Update Post Date:
2025-02-20
Last Update Post Date Type:
ACTUAL